Items where Author is "Frostegård, J"
 | Up a level |
Journal article
POCKLEY, A.G. and FROSTEGÅRD, J., 2005. Heat shock proteins in cardiovascular disease and the prognostic value of heat shock protein-related measurements. Heart, 91, pp. 1124-1126.
BUHLIN, K., GUSTAFSSON, A., FROSTEGÅRD, J., KLINGE, B. and POCKLEY, A.G., 2004. Cardiovascular disease, periodontitis and the monocyte relationship: Reply. European Heart Journal, 25, p. 1366.
CEDERHOLM, A., SVENUNGSSON, E., STENGEL, D., FEI, G.-Z., POCKLEY, A.G., NINIO, E. and FROSTEGÅRD, J., 2004. PAF-acetylhydrolase and other novel risk and protective factors for cardiovascular disease in SLE. Arthritis & Rheumatism, 50, pp. 2869-2876.
POCKLEY, A.G., GEORGIADES, A., THULIN, T., DE FAIRE, U. and FROSTEGÅRD, J., 2004. Response: Is low-heat shock protein 70 a primary or a secondary event in the development of atherosclerosis? Hypertension, 43.
BUHLIN, K., GUSTAFSSON, A., POCKLEY, A.G., FROSTEGÅRD, J. and KLINGE, B., 2003. Risk factors for cardiovascular disease in patients with periodontitis. European Heart Journal, 24, pp. 2099-2107.
POCKLEY, A.G., GEORGIADES, A., THULIN, T., DE FAIRE, U. and FROSTEGÅRD, J., 2003. Serum heat shock protein 70 levels predict the development of atherosclerosis in subjects with established hypertension. Hypertension, 42, pp. 235-238.
POCKLEY, A.G., DE FAIRE, U., KIESSLING, R., LEMNE, C., THULIN, T. and FROSTEGÅRD, J., 2002. Circulating heat shock protein and heat shock protein antibody levels in established hypertension. Journal of Hypertension, 20, pp. 1815-1820.
POCKLEY, A.G., WU, R., LEMNE, C., KIESSLING, R., DE FAIRE, U. and FROSTEGÅRD, J., 2000. Circulating heat shock protein 60 is associated with early cardiovascular disease. Hypertension, 36, pp. 303-307.
Chapter in book
FROSTEGÅRD, J. and POCKLEY, A.G., 2005. Heat shock protein release and naturally-occurring, exogenous heat shock proteins. In: B. HENDERSON and A.G. POCKLEY, eds., Molecular chaperones and cell signalling. New York: Cambridge University Press, pp. 195-219.
